Beam Therapeutics Inc. (BEAM)
NASDAQ·Healthcare·Biotechnology
$24.79
+4.16%
Mkt Cap $2.48B
Analyst Ratings
Buy
7
Hold
0
Sell
0
Price Target (19 analysts)
$59.50
Range $39.00 – $80.00
Implied Upside
+140.1%
Consensus $59.50 vs current $24.79
NASDAQ·Healthcare·Biotechnology
$24.79
+4.16%
Mkt Cap $2.48B
Buy
7
Hold
0
Sell
0
Price Target (19 analysts)
$59.50
Range $39.00 – $80.00
+140.1%
Consensus $59.50 vs current $24.79